A rheumatological perspective on hypertension: a role for disease-modifying antirheumatic drugs?

被引：0

作者：

Poos, Stephen ^{[1
]}

Hassan, Noha ^{[1
]}

Jin, Shan ^{[1
]}

Chuadhry, Ikhtesham ^{[2
]}

Lo, David F. ^{[3
]}

机构：

[1] Stony Brook Southampton Hosp, Dept Internal Med, 240 Meeting House Lane, Southampton, NY 11968 USA

[2] Jefferson Hlth New Jersey, Dept Internal Med, Hill Township, NJ USA

[3] Rowan Virtua Sch Osteopath Med, Dept Med, Stratford, NJ USA

来源：

JOURNAL OF HYPERTENSION | 2025年 / 43卷 / 02期

关键词：

D O I：

10.1097/HJH.0000000000003876

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

引用

页码：359 / 360

页数：2

共 50 条

[31] The Actual Role of Therapy with Traditional Disease-modifying Antirheumatic Drugs in Psoriatic Arthritis [J].

Soriano, Enrique R. .

JOURNAL OF RHEUMATOLOGY, 2012, 39 :67-70

[32] Use of disease-modifying antirheumatic drugs in patients with psoriatic arthritis [J].

Marguerie, L ;

Flipo, RM ;

Grardel, B ;

Beaurain, D ;

Duquesnoy, B ;

Delcambre, B .

JOINT BONE SPINE, 2002, 69 (03) :275-281

[33] Conventional disease-modifying antirheumatic drugs to treat rheumatoid arthritis [J].

Rath, T. ;

Sander, O. ;

Rubbert, A. .

DRUG DEVELOPMENT RESEARCH, 2011, 72 (08) :657-663

[34] Disease-modifying antirheumatic drugs and bone mass in rheumatoid arthritis [J].

Di Munno, O ;

Delle Sedie, A ;

Rossini, A ;

Adamil, S .

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2005, 23 (02) :137-144

[35] Vaccines and Disease-Modifying Antirheumatic Drugs Practical Implications for the Rheumatologist [J].

Friedman, Marcia A. ;

Winthrop, Kevin L. .

RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2017, 43 (01) :1-+

[36] Clinically Important Drug Interactions with Disease-Modifying Antirheumatic Drugs [J].

Cees J. Haagsma .

Drugs & Aging, 1998, 13 :281-289

[37] The effect of disease-modifying antirheumatic drugs on vaccine immunogenicity in adults [J].

Day, Alvin Lee ;

Winthrop, Kevin L. ;

Curtis, Jeffrey R. .

CLEVELAND CLINIC JOURNAL OF MEDICINE, 2020, 87 (11) :695-703

[38] MANAGEMENT OF ADVERSE-EFFECTS OF DISEASE-MODIFYING ANTIRHEUMATIC DRUGS [J].

WIJNANDS, MJH ;

VANRIEL, PLCM .

DRUG SAFETY, 1995, 13 (04) :219-227

[39] Clinically important drug interactions with disease-modifying antirheumatic drugs [J].

Haagsma, CJ .

DRUGS & AGING, 1998, 13 (04) :281-289

[40] PROTOCOL DEVELOPMENT FOR COMBINATION THERAPY WITH DISEASE-MODIFYING ANTIRHEUMATIC DRUGS [J].

PAULUS, HE .

SEMINARS IN ARTHRITIS AND RHEUMATISM, 1993, 23 (02) :19-25

← 1 2 3 4 5 →